Pharmaceutical Executive July 5, 2024
The latest news for pharma industry insiders.
Industry Leaders Discuss the Impact of FDA’s Diversity Action Plan
Pamela Tenaerts, MD, MBA, chief scientific officer, Medable; Luke Gelinas, PhD, senior chair director, Advarra; and Pam Diamond, MD, chief medical officer & co-founder, Curavit highlight the potential impact FDA’s Diversity Action Plan guidance will have on industry.
Early Vaccine Study Shows HIV Neutralizing Antibodies Appear Within Weeks
Elusive HIV antibodies were triggered within weeks during a small-scale HIV vaccine study done at the Duke Human Vaccine Institute, according to a press release posted last month. This finding is significant because it can take years for the body to establish these antibodies. The research was published mid-May in the journal Cell.
Today's Sponsors
Today's Sponsor